SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-002912
Filing Date
2016-08-08
Accepted
2016-08-08 16:01:58
Documents
1
Period of Report
2016-08-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 3956
  Complete submission text file 0001562180-16-002912.txt   5277
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
Dallas Jayson Donald Alexander (Reporting) CIK: 0001650322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 161814112